Pharmaceuticals

Nerve Growth Factor Market Forecast 2026–2035 Reflecting Growth Opportunities Across Industries

March 23, 2026March 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Nerve Growth Factor Market In 2026 And What Value Is Projected For 2030?

The nerve growth factor market has demonstrated robust growth in recent years. Its value is forecast to increase from $1.19 billion in 2025 to $1.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. This historical expansion can be attributed to various factors such as progress in neurobiology research, the clinical development of cenegermin, a rise in neurological disorder prevalence, wider adoption of ophthalmology treatments, and an increase in biologics manufacturing.

The market for nerve growth factors is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $1.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This projected growth is primarily driven by factors such as the increasing prevalence of neurodegenerative conditions, the broadening scope of regenerative medicine initiatives, a rise in clinical trials focused on nerve repair, increased funding for biologics research and development, and advancements in NGF delivery systems. Key trends during this period are expected to encompass intensified research into neuroregeneration therapies, a greater emphasis on treatments for neurodegenerative diseases, the expansion of recombinant protein therapeutics, growing clinical applications in ophthalmic conditions, and enhanced investment in nerve repair technologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22070&type=smp

What Drivers Are Influencing The Nerve Growth Factor Market?

The nerve growth factor market is projected to grow due to the increasing incidence of neurological disorders. These are medical conditions impacting the brain, spinal cord, and nerves, resulting from structural, biochemical, or electrical irregularities. The rising prevalence of neurological disorders can be attributed to an aging population and advancements in diagnostic technology, which enhance the detection and reporting of these conditions, leading to higher recorded incidence rates. Nerve growth factor (NGF) is critical for the maintenance, survival, and regeneration of neurons, thereby acting as a crucial element in addressing neurological disorders by promoting neural repair and potentially slowing disease progression. For instance, in September 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that dementia (a neurological disorder) cases in Australia are expected to increase from about 411,100 in 2023 to 849,300 by 2058. Thus, the escalating prevalence of neurological disorders is a primary driver for the nerve growth factor market’s expansion.

What Are The Key Segments Of The Nerve Growth Factor Market?

The nerve growth factor market covered in this report is segmented –

1) By Type: Alpha-Nerve Growth Factor (NGF), Beta-Nerve Growth Factor (NGF), Gamma-Nerve Growth Factor (NGF), Other Types

2) By Agents: Cenegermin, Other Agents

3) By Indication: Neurodegenerative Disorders, Spinal Cord Injuries, Eye Disorders, Epithelial Diseases, Tissue Healing, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Alpha-Nerve Growth Factor (α-NGF): Natural Alpha-NGF, Recombinant Alpha-NGF, Synthetic Alpha-NGF, Alpha-NGF For Research Applications

2) By Beta-Nerve Growth Factor (β-NGF): Human Beta-NGF, Animal-Derived Beta-NGF, Recombinant Beta-NGF, Therapeutic Beta-NGF, Research-Grade Beta-NGF

3) By Gamma-Nerve Growth Factor (γ-NGF): Natural Gamma-NGF, Recombinant Gamma-NGF, Synthetic Gamma-NGF, Gamma-NGF for Neurodegenerative Research

4) By Other Types: Hybrid NGF Molecules, NGF Mimetics, NGF Gene Therapy-Based Products, NGF-Infused Biomaterials

What Key Trends Are Influencing The Development Of The Nerve Growth Factor Market?

Leading companies in the nerve growth factor market are focusing on developing NGF-targeting biologic therapies, particularly anti-NGF monoclonal antibodies designed to inhibit NGF activity and alleviate chronic pain. Such an anti-NGF monoclonal antibody functions by binding to nerve growth factor, preventing it from activating its receptors, which in turn helps diminish pain signaling and inflammatory responses in patients with degenerative or neuropathic conditions. For instance, in May 2023, Jiangsu Hengrui Pharmaceuticals, a China-based biopharmaceutical company, launched SHR-1314, a next-generation anti-NGF monoclonal antibody approved for clinical evaluation in patients experiencing osteoarthritis-related pain. This therapy exhibits a highly selective binding profile that reduces NGF-mediated sensitization and a long serum half-life, supporting less frequent dosing, with the aim of delivering sustained pain reduction for individuals with chronic joint disease.

Who Are The Leading Companies Operating In The Nerve Growth Factor Market?

Major companies operating in the nerve growth factor market are Dompé farmaceutici S.p.A., Regeneron Pharmaceuticals Inc., Mimetogen Pharmaceuticals, MimeTech Srl, Herantis Pharma, PainCeptor Pharma, Beike Biotechnology, Akeso Inc., Promega Corporation, Enzo Life Sciences Inc., Alomone Labs, Prospec-Tany Technogene Ltd., CUSABIO Technology LLC, Genexis Biotech Pvt. Ltd., Staidson Beijing BioPharmaceuticals, Biomol GmbH, Sino Biological Inc., PeproTech Inc., Abcam plc, Creative BioMart Inc.

Read the full nerve growth factor market report here:

https://www.thebusinessresearchcompany.com/report/nerve-growth-factor-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Nerve Growth Factor Market?

Asia-Pacific was the largest region in the nerve growth factor market in 2025. The regions covered in the nerve growth factor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nerve Growth Factor Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22070&type=smp

Browse Through More Reports Similar to the Global Nerve Growth Factor Market 2026, By The Business Research Company

Nerve Repair And Regenerative Market Report 2026

https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report

Neuromodulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Peripheral Nerve Injuries Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-nerve-injuries-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795